Long before the advent of modern molecular profiling techniques, histopathologists recognised that breast cancer was heterogeneous through morphological observations.
The type and direction of selection are heterogeneous through evolutionary time and vary in ways that would not be readily predicted based solely on organismal performance.
Lung, breast, colorectal and many other cancers have shown to be heterogeneous diseases, which develop through specific molecular alterations that influence the clinical presentation, prognosis and response to therapy [ 1].
I have felt myself to be heterogeneous.
The random component of the intratumour heterogeneity in the uptake of 99mTc-HSA was most likely also caused by the same transport barriers, that is, heterogeneous supply through the tumour microvasculature and inadequate transport through the tumour interstitium.
Colorectal tumors are heterogeneous and evolve through multiple pathways.
These transplanted lines are heterogeneous; however, within a line, through multiple generations, the MIN-Os show consistent growth rate, histopathology, and latency to tumor formation.
Consumers are heterogeneous and can observe neighbour behaviour through social networks.
First, the morphological states are heterogeneous, suggesting that they are not achieved through a single pathway.
Through this comparison, it was found that the behavior was heterogeneous, as post-flight changes in concentrations were protein-dependent.
